View of Reverse phase-hplc method development and validation for the quantitative estimation of brivaracetam in bulk form and marketed pharmaceutical dosage form

View of Reverse phase-hplc method development and validation for the quantitative estimation of brivaracetam in bulk form and marketed pharmaceutical dosage form

Return to Article Details Reverse phase-hplc method development and validation for the quantitative estimation of brivaracetam in bulk form and marketed pharmaceutical dosage form Download Download PDF